Financial Performance - The company reported a revenue of RMB 1.2 billion for the first half of 2022, representing a year-on-year increase of 15% compared to RMB 1.04 billion in the same period of 2021[15]. - The company's operating revenue for the reporting period was ¥655,484,190.95, a decrease of 18.88% compared to ¥808,017,556.58 in the same period last year[21]. - The net profit attributable to shareholders was -¥342,756.98, representing a decline of 112.44% from ¥2,754,479.99 in the previous year[21]. - The company achieved a revenue of 655.48 million yuan, with a net profit attributable to the parent company of -3.43 million yuan, a decrease of 112.44% year-on-year[42]. - The company reported a total revenue of 101,757.5 million yuan for the first half of 2022, reflecting a significant increase compared to the previous period[120]. - The company reported a total revenue of 316.9 million yuan for the first half of 2022, reflecting a 12.6% increase compared to the previous period[126]. - The company reported a total revenue of 1,060 million for the first half of 2022, with a net profit margin of 5.99%[194]. Profitability and Margins - The gross profit margin for the first half of 2022 was 30%, a decrease from 35% in the first half of 2021, indicating increased production costs[15]. - The basic earnings per share decreased to -¥0.0003 from ¥0.0026, reflecting a decline of 111.54% year-on-year[21]. - The net profit for the first half of 2022 was CNY 4,791,214.11, a decline of 17.9% compared to CNY 5,839,070.26 in the first half of 2021[172]. - The company's gross profit margin decreased to 5.5% in the first half of 2022 from 15.5% in the same period of 2021[172]. - The net profit margin for the current period stands at 6.9%, reflecting a stable profitability level despite revenue fluctuations[188]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 50.97% to ¥95,523,028.14 from ¥194,806,461.14 year-on-year[21]. - The net cash flow from operating activities was CNY 95,523,028.14, a decline of 51% compared to CNY 194,806,461.14 in the first half of 2021[178]. - The net cash flow from financing activities increased by 136.51% to ¥67,112,055.07 from -¥183,799,378.42, reflecting an increase in cash received from borrowings[56]. - The total cash and cash equivalents at the end of the period reached CNY 237,904,702.90, an increase of 45.91% from CNY 162,966,868.14 at the end of the previous period[184]. - The company reported a significant increase in cash flow from operations, indicating improved liquidity and operational efficiency[68]. Research and Development - The company plans to invest RMB 200 million in research and development for new products and technologies in the upcoming year[15]. - Research and development investment increased by 7.28% to ¥29,777,274.87 from ¥27,756,948.45, indicating a continued focus on innovation[56]. - The company aims to enhance its research and development capabilities to innovate and improve product offerings in the upcoming quarters[191]. Market Expansion and Strategy - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 20% market share in the region by 2025[15]. - The company plans to expand its overseas market presence in the U.S., Europe, and Southeast Asia, focusing on the industrial hemp market[34]. - The company is actively expanding its industrial hemp business, focusing on application scenarios in health products and new tobacco products[45]. - The company is accelerating its layout in new tobacco, new materials, and organic agriculture sectors, indicating a diversification of its development strategy[93]. - The company is increasing its overseas market presence to mitigate the impact of policy uncertainties on its operations[97]. Risks and Challenges - The company faces risks related to supply chain disruptions and fluctuating raw material prices, which may impact future profitability[15]. - The resurgence of COVID-19 in Shanghai and intensified US-China trade tensions have increased macroeconomic and operational risks, leading to decreased purchasing power[99]. - The company is actively seeking to mitigate risks associated with the tobacco industry's potential decline in consumption due to increased public awareness of health issues[83]. Legal and Compliance Issues - The company is involved in a lawsuit with Shanghai Lvxin Ziguang Intelligent Equipment Co., Ltd. regarding technology infringement, with the claimed amount of 10 million yuan[119]. - The company has not faced any significant environmental penalties during the reporting period and adheres to environmental protection regulations[109]. - The half-year financial report has not been audited, indicating a need for further financial scrutiny[116]. Shareholder Information - No cash dividends or stock bonuses will be distributed to shareholders for the current fiscal year[4]. - A total of 138 employees participated in the employee stock ownership plan, holding 6,832,000 shares, which represents 0.64% of the company's total equity[106]. - The company’s board members and senior management maintained their shareholdings during the reporting period, with the largest individual holding being 1,516,000 shares by the vice chairman[106]. Asset Management - The total assets at the end of the reporting period increased by 1.26% to ¥2,908,194,676.81 from ¥2,872,056,822.91 at the end of the previous year[21]. - The company's total equity reached CNY 2,067,427,732.96, slightly up from CNY 2,062,297,264.63 in the previous year[172]. - The total liabilities increased to CNY 804,924,878.35 from CNY 764,205,862.71, reflecting a rise of about 5.3%[165].

Financial Performance - The company's revenue for Q1 2022 was ¥357,336,483.33, a decrease of 20.36% compared to ¥448,696,717.07 in the same period last year[2] - The net profit attributable to shareholders was a loss of ¥2,890,178.08, representing a decline of 349.16% from a profit of ¥1,159,975.35 in the previous year[2] - Total operating revenue for Q1 2022 was CNY 357,336,483.33, a decrease of 20.4% compared to CNY 448,696,717.07 in the same period last year[22] - The company reported a total profit of 2,994,393.76 CNY, down from 7,902,279.32 CNY in the same period last year, showing a decrease of approximately 62%[24] - The total comprehensive income for the period was 894,480.88 CNY, down from 3,324,756.83 CNY, indicating a decline in overall financial health[24] Cash Flow and Liquidity - The net cash flow from operating activities increased by 13.63% to ¥117,276,755.45, compared to ¥103,206,240.75 in the same period last year[2] - The net cash flow from operating activities increased to 117,276,755.45 CNY, up from 103,206,240.75 CNY in the previous year, reflecting improved operational efficiency[28] - The company experienced a net cash outflow from investing activities of -17,628,302.11 CNY, compared to -20,277,787.93 CNY in the previous year, showing a slight improvement[28] - The cash and cash equivalents at the end of the period were 327,295,999.59 CNY, down from 470,529,102.22 CNY year-over-year, indicating a liquidity contraction[28] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,801,698,876.91, down 2.45% from ¥2,872,056,822.91 at the end of the previous year[2] - Total assets decreased to CNY 2,801,698,876.91 from CNY 2,872,056,822.91, a decline of 2.5%[20] - Total liabilities decreased to CNY 696,953,435.86 from CNY 764,205,862.71, reflecting a reduction of 8.8%[20] - Total equity decreased to CNY 2,104,745,441.05 from CNY 2,107,850,960.20, a slight decline of 0.1%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 74,744[10] - The largest shareholder, Shunhao Investment Group, holds 22.27% of shares, totaling 236,063,750 shares[10] - Wang Dan, a significant shareholder, owns 8.49% of shares, amounting to 89,982,504 shares[10] - The company has a total of 29,335,112 shares held through margin trading by its top shareholders[11] Investment and Development - The company reported a significant increase in investment income, which rose by 523.43% to ¥7,044,076.68 from a loss of ¥1,663,561.20 in the previous year[8] - The company is expanding its presence in the electronic cigarette industry, leveraging early entry advantages and technical expertise[12] - A partnership has been established with TAAT Global Alternatives Inc. to develop a non-combustible industrial hemp heating device and three proprietary flavors[13] - The company plans to enhance product development and production processes to adapt to new industry regulations and increase market share[12] - The company is focusing on optimizing its production capabilities to meet new regulatory standards in the electronic cigarette market[12] Legal and Regulatory Matters - The company is involved in a legal dispute regarding construction projects, with potential liabilities estimated at approximately 12.48 million RMB[14] - The company has completed payment obligations related to the construction projects as of March 31, 2022[14] - The company paid CNY 1,600,000.00 as a quality guarantee deposit related to a legal case, which is 5% of the total project cost[16] Expenses and Costs - The company's sales expenses decreased by 39.87% to ¥14,914,859.45 due to a change in accounting policy[8] - Total operating costs for Q1 2022 were CNY 358,994,985.21, down from CNY 439,889,034.69 in the previous year, reflecting a reduction of 18.4%[22] - Research and development expenses were 12,134,280.68 CNY, a decrease from 14,550,417.77 CNY, indicating a reduction in investment in innovation[24] - The company reported a significant increase in financial expenses, with interest expenses rising to 3,318,308.84 CNY from 2,861,250.97 CNY, reflecting higher borrowing costs[24]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year increase of 15% compared to 2020[1]. - The net profit attributable to shareholders was RMB 150 million, which is a 10% increase from the previous year[1]. - The company's operating revenue for 2021 was ¥1,550,233,440.26, a decrease of 3.03% compared to ¥1,598,674,368.85 in 2020[22]. - The net profit attributable to shareholders was a loss of ¥28,288,619.52, representing a decline of 461.25% from a profit of ¥7,830,783.21 in 2020[22]. - The net cash flow from operating activities increased by 90.17% to ¥269,439,249.48, up from ¥141,679,754.02 in 2020[22]. - The total assets at the end of 2021 were ¥2,872,056,822.91, a decrease of 4.94% from ¥3,021,169,640.04 at the end of 2020[22]. - The net assets attributable to shareholders decreased by 1.36% to ¥1,921,906,722.49 from ¥1,948,429,527.63 in 2020[22]. - The basic earnings per share for 2021 was -¥0.0267, a decline of 460.81% from ¥0.0074 in 2020[22]. - The company achieved a total revenue of 1,550.23 million CNY, with a net profit attributable to the parent company of -28.29 million CNY for the reporting period[55]. - The company's total assets reached 2,872.06 million CNY, with a net asset value of 1,921.91 million CNY and a debt-to-asset ratio of 26.61%[55]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share in the region by 2025[1]. - Future guidance indicates a projected revenue growth of 18% for 2022, aiming for a total revenue of RMB 1.42 billion[1]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[1]. - The company is expanding its market presence in overseas regions, including the U.S. and Southeast Asia, to enhance its product offerings in the industrial hemp sector[42]. - The company is actively seeking innovative eco-friendly packaging applications in the food and cosmetics industries[38]. - The company is focusing on five main business areas: special eco-friendly paper sales, trademark printing, industrial hemp processing, new tobacco products, and organic agriculture[37]. - The company aims to enhance its market share in green packaging by accelerating the transformation of technological achievements[33]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence[173]. Research and Development - The company has allocated RMB 100 million for research and development in new technologies for sustainable materials[1]. - The company is investing in R&D, allocating 10% of its revenue towards developing new technologies and products[173]. - The company is focusing on innovation and customization in packaging solutions, utilizing advanced technologies to meet diverse customer needs[51]. - The company is enhancing its research and development capabilities in new tobacco products, establishing a comprehensive industry chain for production and sales[62]. - The company aims to establish a crystallization process for CBD with over 95% purity, which is expected to have significant market value[87]. - The company has completed the development of a new high-barrier coating technology, which is expected to enhance product performance and market competitiveness[90]. Product Development and Launches - New product development includes the launch of a biodegradable packaging solution, expected to contribute an additional RMB 200 million in revenue in 2022[1]. - The company has launched the "Vitaldiol—R" series products in the U.S. market, which include CBD and other natural ingredients, reflecting a focus on the biopharmaceutical industry and global market opportunities[42]. - The company has launched innovative industrial hemp products, including Elon CBD awakeners and Stem full-spectrum CBD awakeners, which are now available for sale[59]. - The company developed four new flavors for its vape cartridges, expanding its product line[87]. Risk Management - Risk analysis indicates potential challenges in supply chain disruptions, with strategies in place to mitigate these risks[1]. - The company has indicated uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years[22]. - The company is facing risks related to its heavy reliance on the tobacco industry, which is subject to regulatory changes that could impact its operations and profitability[135]. - The ongoing COVID-19 pandemic and international trade tensions are posing risks to the company's operations, affecting consumer purchasing power and increasing international shipping costs[139]. Corporate Governance and Management - The company has established a robust internal control system in line with regulatory requirements, continuously improving its internal processes[148]. - The company has maintained compliance with relevant laws and regulations throughout its operations[183]. - The company held 9 board meetings during the reporting period, ensuring compliance with legal and regulatory requirements[145]. - The company has a diverse management team with backgrounds in finance, technology, and international trade, enhancing its strategic capabilities[158][159][160]. - The company reported a significant leadership change with several executives completing their terms, including Vice President Yuan Chen and Independent Director Xu Jianxin[156]. Employee and Shareholder Relations - The total remuneration for directors, supervisors, and senior management in 2021 amounted to CNY 12.70 million[176]. - The employee stock ownership plan includes 138 employees holding a total of 6,832,000 shares, representing 0.64% of the company's total share capital[194]. - The company has implemented a performance-based salary policy, linking salary adjustments to company and employee performance[189]. - The company has developed targeted training programs for high-potential key talents and core management personnel[191]. Sustainability and Compliance - The company is focusing on sustainable production practices, including the development of biodegradable packaging products and the implementation of RTO waste gas treatment equipment[48]. - The company is committed to complying with national regulations and continuously improving its product offerings in the new tobacco sector[36]. - The company is committed to complying with international regulations regarding industrial hemp and is enhancing its management systems to ensure legal and compliant operations in this sector[138].

Financial Performance - The company's revenue for Q3 2021 was ¥335,676,452.19, a decrease of 16.85% compared to the same period last year[2] - The net profit attributable to shareholders was -¥12,582,626.51, representing a decline of 327.69% year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥13,346,869.62, down 235.01% from the previous year[2] - Total operating revenue for Q3 2021 was CNY 1,143,694,008.77, an increase from CNY 1,119,991,979.88 in Q3 2020, representing a growth of approximately 2.3%[20] - The net profit for Q3 2021 was a loss of CNY 5,611,804.19, compared to a profit of CNY 12,630,247.66 in Q3 2020, reflecting a significant decline[22] - The company recorded a total comprehensive income of -CNY 5,346,905.60 for Q3 2021, compared to CNY 11,509,199.76 in Q3 2020, reflecting a significant decline in overall performance[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,821,244,513.77, a decrease of 6.62% from the end of the previous year[2] - The company's total assets decreased to CNY 2,821,244,513.77 from CNY 3,021,169,640.04 in the previous quarter, a reduction of approximately 6.6%[19] - Total liabilities decreased to CNY 694,897,842.10 from CNY 882,530,700.39, marking a decline of about 21.2%[19] - The company's equity attributable to shareholders was ¥1,938,494,209.34, down 0.51% from the previous year-end[2] - The total equity attributable to shareholders of the parent company was CNY 1,938,494,209.34, down from CNY 1,948,429,527.63, a decrease of approximately 0.5%[19] Cash Flow - The operating cash flow for the year-to-date was ¥203,936,474.42, an increase of 34.88% compared to the same period last year[8] - Operating cash flow for the period was CNY 203,936,474.42, an increase of 35% compared to CNY 151,203,409.46 in the previous period[25] - Total cash inflow from operating activities was CNY 1,333,839,440.73, slightly up from CNY 1,329,234,900.37 year-on-year[25] - Cash outflow from operating activities decreased to CNY 1,129,902,966.31 from CNY 1,178,031,490.91, reflecting improved cost management[25] - The company reported a net decrease in cash and cash equivalents of CNY 17,309,175.58, compared to a larger decrease of CNY 116,804,756.52 in the previous period[26] - The ending balance of cash and cash equivalents was CNY 466,710,773.57, down from CNY 488,587,879.20 year-on-year[26] Receivables and Inventory - Accounts receivable decreased by 32.09% to ¥283,252,294.82, indicating improved cash collection[7] - Accounts receivable decreased to RMB 283,252,294.82 from RMB 417,110,690.03, indicating a reduction of about 32.1%[17] - Inventory decreased to RMB 433,555,893.51 from RMB 515,523,595.71, reflecting a decline of approximately 16%[17] Investments and Partnerships - The company invested RMB 150 million in Qinghai Jintai Potash Fertilizer Co., Ltd. to extend its industrial chain and explore cooperation in the tobacco industry[13] - A cooperation agreement was signed with Monkey Happy (Beijing) International Travel Agency to promote low-temperature herbal products and industrial hemp products through their extensive offline sales channels[12] - The company has established a strategic partnership to enhance market expansion and product sales in the herbal and industrial hemp sectors[12] Legal and Regulatory Matters - The company is involved in a legal dispute regarding construction projects, with an expected payment of approximately RMB 12.48 million due to a court ruling[15] - The company is actively cooperating with authorities in a criminal case involving former shareholders of its subsidiary, Zhejiang Demai Printing Co., Ltd., suspected of contract fraud[15] Other Financial Metrics - The company recognized government subsidies amounting to ¥770,948.25 during the reporting period, contributing to its non-operating income[4] - Research and development expenses for Q3 2021 were CNY 39,944,089.58, slightly down from CNY 42,281,907.34 in Q3 2020, indicating a decrease of about 5.5%[20] - The company reported a basic earnings per share of -0.0093 for Q3 2021, compared to 0.0062 in Q3 2020, indicating a negative shift in profitability[22] - The company completed the cancellation of 168,000 repurchased shares, reducing its registered capital and modifying its articles of association[12] Cash Management - The company received CNY 278,000,000.00 from other investment activities, significantly higher than CNY 83,037,671.00 in the previous period[26] - Cash inflow from financing activities was CNY 92,589,575.81, down from CNY 430,413,250.00 in the previous period, indicating reduced borrowing[26] - Investment activities resulted in a net cash outflow of CNY 81,464,615.24, an improvement from a net outflow of CNY 141,253,962.29 in the previous period[26] Audit and Standards - The company has not undergone an audit for the third quarter report[28] - The company has not applied new leasing standards for the financial statements[27]

Financial Performance - The company reported a revenue of RMB 1.2 billion for the first half of 2021, representing a year-on-year increase of 15% compared to RMB 1.04 billion in the same period of 2020[1]. - The net profit attributable to shareholders was RMB 200 million, up 20% from RMB 166.67 million in the first half of 2020[1]. - The company's operating revenue for the reporting period was ¥808,017,556.58, representing a 12.80% increase compared to ¥716,302,797.23 in the same period last year[22]. - The net profit attributable to shareholders was ¥2,754,479.99, a significant increase of 172.64% from ¥1,010,293.75 in the previous year[22]. - The company achieved operating revenue of 808.02 million yuan, with a net profit attributable to the parent company of 2.75 million yuan, representing a year-on-year growth of 172.64%[40]. - The company reported a basic earnings per share of ¥0.0026, which is a 160.00% increase from ¥0.0010 in the previous year[22]. - The company reported a total revenue of 214.72 million yuan for the first half of 2021, with a net profit of 13.48 million yuan, reflecting a significant contribution from its subsidiaries[81]. - The company reported a total of 454.80 million yuan in expected daily related transactions for 2021, with actual transactions not exceeding this amount[121]. Market Expansion and Strategy - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 30% market share in the region by 2023[1]. - The company plans to invest RMB 300 million in new product development and technology research in the next fiscal year[1]. - Future guidance estimates a revenue growth of 20% for the second half of 2021, projecting total revenue to reach RMB 2.4 billion for the full year[1]. - The company is focusing on expanding its packaging materials production and sales, which is a key area for future growth[81]. - The company plans to continue enhancing product quality and technology while expanding into international markets[52]. - The company aims to evolve from a single new tobacco device manufacturer to a comprehensive new tobacco industry chain manufacturer and seller, leveraging its unique patent for a needle-shaped cigarette igniter[89]. Research and Development - The company is committed to R&D innovation to maintain a competitive edge and enhance customer loyalty[87]. - The company is actively seeking innovative applications for its environmentally friendly packaging in industries such as food and cosmetics[31]. - The company has maintained a competitive advantage in the special anti-counterfeit environmentally friendly paper market by participating in the formulation of national industry standards[31]. - The company holds a total of 339 patents, including 26 invention patents, and has 63 patents pending, which supports its technological development in the industry[47]. - The company is focusing on new tobacco, new materials, and organic agriculture, indicating a diversification strategy to enhance growth[84]. Sustainability and Environmental Practices - The company is focusing on sustainable practices in its operations, aiming to reduce carbon emissions by 15% by 2025[1]. - The company emphasizes sustainable production processes and has introduced biodegradable packaging products, achieving certifications for compostable packaging[48]. - The company does not belong to the key pollutant discharge units as published by the environmental protection department, and no administrative penalties were incurred during the reporting period[104]. - The company has a sound environmental protection system and has complied with relevant laws and regulations, with all environmental indicators meeting standards during the reporting period[104]. Risks and Challenges - The management highlighted potential risks including market competition and supply chain disruptions, with strategies in place to mitigate these risks[1]. - The company is facing risks related to industry policy adjustments, particularly in the tobacco sector, which could impact its operations due to regulatory changes[85]. - The company is facing increased operational risks due to the impacts of COVID-19 and international trade conflicts, but is maintaining stable business development through various measures[92]. Legal and Compliance Issues - The company has recognized a total compensation liability of approximately 10,427.6 million yuan due to litigation related to information disclosure violations, with 50-60% of this amount expected to be compensated[113]. - The company is actively managing its legal risks and has taken steps to mitigate potential financial impacts from ongoing litigation[116]. - The company has faced administrative penalties and fines from the China Securities Regulatory Commission, impacting its financial standing[113]. - The company is closely monitoring the regulatory environment for new tobacco products, which is crucial for its future business development[88]. Subsidiaries and Investments - The subsidiary Yunnan Province Yuxi Printing Co., Ltd. generated a revenue of 60.35 million yuan and a net profit of 10.01 million yuan, accounting for over 10% of the company's net profit[81]. - The company has established a subsidiary, LUXIN HEMP, in the U.S. to engage in industrial hemp processing and manufacturing, aiming to capture market demand for CBD and related products[33]. - The company has made significant equity investments totaling ¥14,294,860.00 in new ventures, including electronic products and industrial hemp[73]. - The company has established two new consolidated entities: Shanghai Shunhao Yilong Electronic Technology Co., Ltd. and Green Xin Co., Ltd.[198]. Financial Position and Assets - The company's total assets decreased by 6.35% to ¥2,829,217,767.87 from ¥3,021,169,640.04 at the end of the previous year[22]. - Cash and cash equivalents decreased to ¥475,667,450.80, representing 16.81% of total assets, down from 18.16%[64]. - The company’s total liabilities were not disclosed, but the net asset position suggests a stable financial structure[81]. - The total equity at the end of the reporting period is CNY 2,037,851,000, showing an increase from CNY 2,036,369,000 at the beginning of the year[193]. Shareholder Information - The largest shareholder, Shunhao Investment Group, holds 22.27% of the shares, amounting to 236,063,750 shares, with 39,836,100 shares pledged[148]. - The second largest shareholder, Wang Dan, holds 11.41% of the shares, totaling 120,933,700 shares, with 60,107,392 shares pledged[148]. - The company has approved an employee stock ownership plan to enhance employee engagement and retention[99]. - The company completed the employee stock ownership plan with a total of 6,832,000 shares transferred through non-trading transfer[101].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2020, representing a year-on-year increase of 15% compared to 2019[15]. - The net profit attributable to shareholders was RMB 150 million, which is a 10% increase from the previous year[15]. - The company's operating revenue for 2020 was ¥1,598,674,368.85, a decrease of 7.82% compared to ¥1,734,366,846.10 in 2019[20]. - The net profit attributable to shareholders in 2020 was ¥7,830,783.21, a significant increase of 103.95% from a loss of ¥198,378,903.28 in 2019[20]. - The net profit after deducting non-recurring gains and losses was ¥25,502,154.59 in 2020, improving by 111.44% from a loss of ¥222,880,644.47 in 2019[20]. - The company reported a basic earnings per share of ¥0.0074 in 2020, compared to a loss of ¥0.1871 in 2019, marking a 103.96% improvement[20]. - The total revenue for the company was 1,600,000,000.00 CNY, representing a decrease of 15.46% compared to the previous year[69]. - The professional packaging printing segment saw a significant decline in revenue, dropping by 30.80% year-on-year, contributing CNY 434.32 million to total revenue[68]. - The company reported a significant increase in revenue from new tobacco products, which reached 6,871,061.21 CNY, a 165.23% increase compared to the previous year[69]. Strategic Initiatives - The company plans to invest RMB 200 million in research and development for new products and technologies in 2021[15]. - The company has initiated a strategic partnership with a leading technology firm to enhance its product offerings and market reach[15]. - The company is exploring potential acquisitions to strengthen its position in the new materials sector, with a budget of RMB 300 million allocated for this purpose[15]. - The company is focusing on expanding its market presence in Southeast Asia, targeting a 30% increase in sales from this region[15]. - The company is focusing on two main strategic lines: "environmental new materials" and "biological health," expanding into five major business areas including special environmental paper sales and industrial hemp processing[29]. - The company plans to actively promote the development of industrial hemp cultivation and processing, as well as applications in the biological health sector[29]. - The company is focusing on optimizing its product structure and diversifying its product lines in response to increased competition in the packaging industry[55]. Market Outlook - The company has outlined a future outlook aiming for a revenue growth of 20% in 2021, driven by market expansion and new product launches[15]. - The global industrial hemp market is projected to reach approximately $10 billion by 2024, with a significant increase in demand for CBD products, which saw U.S. sales grow by 706% in 2019[37]. - The packaging industry is expected to grow from $806.3 billion in 2016 to $1,162.1 billion by 2026, with a compound annual growth rate of 3.8%, highlighting the potential for environmentally friendly packaging solutions[36]. - The European cannabis market is projected to grow from $3.4981 billion in 2019 to $36.9971 billion by 2027, with a compound annual growth rate of 29.6%[127]. Research and Development - The company is enhancing its research and development capabilities in organic agriculture, focusing on bio-organic fertilizers and soil remediation products[35]. - The company is enhancing its research and development capabilities with a focus on new materials and technologies, particularly in environmentally friendly packaging solutions[56]. - The company is committed to increasing its investment in technology research and development to improve its competitive edge in the market[123]. - The company is leveraging its industry chain advantages to explore new business opportunities in the industrial hemp sector, aiming for significant profit growth[54]. Risk Management - The company has identified risks related to market competition and regulatory changes, which may impact future performance[5]. - The company is exposed to industry policy adjustment risks, particularly in the tobacco sector, which could impact its operations due to regulatory changes[132]. - The company faces operational management risks due to rapid expansion and will strengthen training and management of subsidiary teams to mitigate these risks[131]. Subsidiaries and Investments - The company has established multiple subsidiaries across various provinces, enhancing its production capabilities and reducing costs while maintaining stable supply relationships with key clients[50]. - The company has established new subsidiaries, including Vitaldiol Pharmaceutical LLC and LHS Industry LLC, to expand its market presence[40]. - The company has completed the planting of 1,000 acres of industrial hemp and is advancing its processing construction projects, with major production and testing equipment installed[58]. - The company has established several subsidiaries, including Vitaldiol Pharmaceutical LLC and Heilongjiang Shunhao Hemp Biotechnology Co., enhancing its operational capabilities[115]. Shareholder Returns - No cash dividends will be distributed to shareholders for the fiscal year 2020, as the company aims to reinvest profits into growth initiatives[6]. - The accumulated undistributed profits for 2020 will be carried over to the next year to meet external investment and operational needs[148]. - The company has not distributed cash dividends in the past three years, with the last dividend distribution being in 2018, where it distributed 2.016664 RMB per 10 shares[146]. Legal and Compliance - The company is currently involved in significant litigation, with a potential liability of ¥10,427,600 related to administrative penalties imposed by the China Securities Regulatory Commission[167]. - The company has been involved in multiple lawsuits related to compensation claims, with ongoing appeals and court proceedings[168]. - The company has recognized an estimated liability of 80% of the claimed amount, totaling CNY 83.420798 million, with specific provisions recorded in previous years[169]. - The company is committed to complying with the 1961 Convention and local regulations regarding industrial hemp, ensuring legal and compliant operations[138].

Financial Performance - The company's revenue for Q1 2021 was ¥448,696,717.07, representing a 69.72% increase compared to ¥264,370,916.00 in the same period last year[7] - Net profit attributable to shareholders was ¥1,159,975.35, a significant turnaround from a loss of ¥7,935,943.96 in the previous year, marking a 114.62% improvement[7] - The net profit after deducting non-recurring gains and losses was ¥1,241,708.81, compared to a loss of ¥7,992,555.15 last year, reflecting a 115.54% increase[7] - Basic earnings per share improved to ¥0.0011 from a loss of ¥0.0075, indicating a 114.67% increase[7] - The company reported a net profit of ¥2,927,327.79, a recovery from a net loss of ¥6,573,885.43 in the same quarter last year[46] - The company reported a total comprehensive income of CNY 1,249,402.20 for Q1 2021, down from CNY 8,306,399.23 in the same quarter last year, indicating a decline of approximately 85%[51] Cash Flow - The net cash flow from operating activities reached ¥103,206,240.75, a remarkable increase of 478.07% from a negative cash flow of ¥27,298,100.67 in the same period last year[7] - The cash flow from operating activities improved significantly, reaching CNY 103.21 million, a 478.07% increase compared to the previous period[16] - The net cash flow from investment activities was 53,112,287.11 CNY, compared to a negative cash flow of -64,461,285.00 CNY in the previous year[58] - The total cash inflow from investment activities amounted to 131,514,474.71 CNY, significantly higher than 13,300,000.00 CNY in the same period last year[58] - The cash inflow from financing activities was 150,000,000.00 CNY, with no cash received from other financing activities[58] - The cash outflow for debt repayment was 30,000,000.00 CNY, significantly lower than 280,000,000.00 CNY in the previous year[58] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,968,284,189.36, a decrease of 1.75% from ¥3,021,169,640.04 at the end of the previous year[7] - The total liabilities decreased to CNY 832,320,492.88 from CNY 882,530,700.39, a decrease of about 5.68%[38] - The total amount of raised funds used by the company from the beginning of the year to the end of the reporting period was 1,482,500 CNY, with a cumulative usage of 124,183,000 CNY[26] - The balance of the raised funds account as of March 31, 2021, was 29,423,400 CNY[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 64,281[11] - The net assets attributable to shareholders were ¥1,949,986,932.02, showing a slight increase of 0.08% from ¥1,948,429,527.63 at the end of the previous year[7] - Total equity attributable to shareholders increased slightly to CNY 1,949,986,932.02 from CNY 1,948,429,527.63, an increase of approximately 0.08%[39] Regulatory and Market Developments - The company is closely monitoring regulatory developments in the new tobacco industry to ensure compliance and capitalize on market opportunities[19] - The company aims to expand its presence in Southeast Asia and Europe for new tobacco products while leveraging supply chain advantages[19] Other Financial Metrics - The company reported non-recurring gains and losses totaling -¥81,733.46 for the period[8] - The company incurred a tax expense of CNY 694,877.58 in Q1 2021, which was not reported in the previous year[50] - Research and development expenses for the quarter were ¥14,550,417.77, slightly higher than ¥13,604,029.97 in the previous year[45] - Investment income decreased significantly by 710.26% to a loss of CNY 1.66 million due to reduced profits from associated companies[16]

Financial Performance - Operating revenue for the reporting period was CNY 403,689,182.65, an increase of 1.77% year-on-year, while year-to-date revenue decreased by 13.26% to CNY 1,119,991,979.88[7] - Net profit attributable to shareholders was CNY 5,526,141.68, down 61.34% year-on-year, with year-to-date net profit decreasing by 91.09% to CNY 6,536,435.43[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 9,885,685.28, a decrease of 41.06% year-on-year[7] - Basic and diluted earnings per share were both CNY 0.0052, representing a decrease of 61.48% year-on-year[7] - The weighted average return on equity was 0.28%, down 0.39% compared to the previous year[7] - The net cash flow from operating activities was CNY 60,057,464.31, down 44.61% compared to the same period last year[7] - The total profit for Q3 2020 was CNY 11,470,440.30, down from CNY 20,434,473.22 in Q3 2019, reflecting a decrease of approximately 43.9%[58] - The net profit for Q3 2020 was CNY 8,669,922.84, down from CNY 15,048,502.71 in Q3 2019, indicating a decrease of about 42.5%[58] - The profit attributable to the parent company's shareholders was CNY 5,526,141.68, compared to CNY 14,292,667.43 in the previous year, reflecting a decline of approximately 61.2%[58] - The total comprehensive income for Q3 2020 was CNY 7,157,531.72, down from CNY 15,516,804.57 in Q3 2019, a decrease of about 53.8%[58] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,996,453,177.70, a decrease of 1.98% compared to the end of the previous year[7] - The company's total assets decreased to CNY 2,670,670,468.43 as of September 30, 2020, down from CNY 2,777,563,352.02 at the end of 2019[52] - The total current assets were reported at CNY 1,707,861,058.85, down from CNY 1,776,512,184.62, indicating a decrease of about 3.9%[45] - The total liabilities increased to CNY 1,710,000,000.00, compared to CNY 1,600,000,000.00 in the previous year, showing an increase of about 6.9%[45] - The company's cash and cash equivalents decreased to CNY 532,275,653.85 from CNY 629,529,800.49 at the end of 2019, reflecting a decline of approximately 15.4%[45] Cash Flow - The net cash flow from operating activities decreased by 31.79% to 151,203,409.46 from 221,675,924.60, impacted by increased cash payments for goods due to inventory buildup[16] - The net cash flow from investing activities was -141,253,962.29, reflecting significant expenditures on fund purchases[16] - Total cash inflow from operating activities was ¥1,329,234,900.37, while cash outflow was ¥1,178,031,490.91, resulting in a net cash flow of ¥151,203,409.46[72] - Cash inflow from investment activities was ¥107,200,421.39, down 55.2% from ¥239,433,462.29 in the previous year[73] - The net cash flow from financing activities was -¥125,616,183.58, compared to -¥218,440,318.66 in Q3 2019, showing an improvement[73] Shareholder Information - The total number of shareholders at the end of the reporting period was 69,702[11] - The largest shareholder, Shunhao Investment Group Co., Ltd., held 22.27% of the shares, amounting to 236,063,750 shares[11] Investments and Projects - Trading financial assets increased by 210.25% to 43,350,426.99 from 13,972,816.00 due to investments in a private equity fund[15] - The company has recognized a provision for litigation losses amounting to 80% of the claimed damages totaling 10,427.5997 million, with various amounts recorded as extraordinary expenses over several years[17] - The company received a total of 40,139,414.18 from the bankruptcy liquidation of its former subsidiary, with distributions occurring in multiple phases[19] - The company is actively cooperating with law enforcement regarding a criminal investigation into alleged fraud by former shareholders of its subsidiary[21] - The company holds a 40% stake in Shenzhen Meizhonglian Technology, which has a strong R&D team and is preparing for overseas market expansion[27] Research and Development - The company has filed 119 industrial hemp patents, with 109 passing initial review, establishing a strong technical barrier for future product development[22] - Research and development expenses for Q3 2020 were CNY 13,206,307.05, down from CNY 16,260,751.27 in the previous period, suggesting a potential shift in R&D focus[56] - The company's research and development expenses were CNY 13.73 million, a decrease of 23.3% from CNY 17.95 million in the previous year[67] Product Development - Yunnan Green has completed the planting of 1,000 acres of industrial hemp, with male hemp harvesting initiated and female hemp expected to be harvested by late October[23] - The first phase of the industrial hemp processing project in Heilongjiang has been signed, with plans for 500 to 1,000 acres of trial planting and product line construction[23] - The company has launched its own brands of industrial hemp products, including Elon CBD awakeners and Stem full-spectrum CBD sticks, which are now available for sale[24] - Shanghai Green has signed an investment agreement for a project to manufacture 200 million heat-not-burn sticks annually, enhancing product variety and market share[26] - The second-generation FreeM automatic heat-not-burn vaporizer has been fully upgraded, significantly improving user experience and achieving automated mass production[27] Financial Management - The company reported a total of CNY 8,800,000.00 in entrusted financial management, with CNY 500,000.00 overdue[36] - The long-term equity investments stood at CNY 264,503,944.54, slightly up from CNY 263,998,424.31 at the end of 2019[46] - There were no derivative investments during the reporting period, indicating a conservative investment strategy[33]

Financial Performance - The company's operating revenue for the reporting period was ¥716,302,797.23, a decrease of 19.92% compared to ¥894,460,591.59 in the same period last year[19]. - The net profit attributable to shareholders was ¥1,010,293.75, down 98.29% from ¥59,055,239.89 year-on-year[19]. - The net profit after deducting non-recurring gains and losses was ¥20,363,332.20, a decline of 47.34% compared to ¥38,672,878.85 in the previous year[19]. - The company's total assets at the end of the reporting period were ¥2,998,339,160.99, a decrease of 1.92% from ¥3,057,130,864.56 at the end of the previous year[19]. - The basic earnings per share decreased to ¥0.0010 from ¥0.0557, reflecting a decline of 98.20% year-on-year[19]. - The company achieved operating revenue of 716.30 million yuan and a net profit attributable to the parent company of 1.01 million yuan during the reporting period[48]. - The company reported a total of approximately 11.09 million yuan in claims related to construction quality and schedule violations[113]. - The total sales revenue for the company during the reporting period amounted to 254.4 million yuan, with a market price of 342.24 million yuan[120]. Investments and Assets - The company’s trading financial assets increased by 35.56 million yuan, a growth of 254.48%, due to investments in private equity funds[38]. - The company made significant investments totaling 97.37 million yuan during the reporting period, marking a dramatic increase of 3,613.69% compared to the previous year[73]. - The company has established over 20 wholly-owned or controlling subsidiaries across various provinces, indicating significant expansion in its operational scale[98]. - The company has filed 109 invention patents related to the industrial hemp industry chain, with 89 patents passing initial review by the National Intellectual Property Administration[51]. - The company has a total of 332 patents, including 36 invention patents, 61 design patents, and 235 utility model patents, with 20 new patents added in the first half of 2020[42]. Business Development and Strategy - The company is committed to a strategic layout around "environmental new materials + biological health," focusing on five main business areas including special environmental paper sales and organic agriculture[27]. - The company has expanded its business into industrial hemp cultivation and processing, and has obtained the necessary licenses for operations in Yunnan Province[30]. - The company is actively developing application scenarios for industrial hemp, including the production of daily chemical products such as masks and massage creams[30]. - The company is focusing on new business areas such as new tobacco, new materials, and organic agriculture, which diversifies its development strategy[98]. - The company plans to accelerate the research and development of CBD-based daily care and beauty products, focusing on overseas markets for applications in pain management and mental health[31]. Legal and Compliance Issues - The company faces a total compensation claim of 103.5884 million yuan related to information disclosure violations[111]. - The company has recognized an estimated liability of 80% of the claimed amount, totaling approximately 82.87072 million yuan, which has been accounted for in various financial periods[112]. - The company has been involved in multiple lawsuits, with some cases already reaching the execution stage[110]. - The company is actively managing its legal risks and has taken steps to mitigate potential financial impacts from these lawsuits[112]. Market and Industry Trends - The global industrial hemp market is projected to reach approximately $10 billion by 2024, driven by increasing demand across various industries[35]. - The new tobacco product market reached $27.74 billion in 2018, with a year-on-year growth of 60.6%, and is expected to exceed 82 million users by 2023[37]. - The Chinese packaging industry is expected to exceed 2 trillion yuan in sales revenue by 2023, with a focus on green and environmentally friendly packaging solutions[34]. Operational Challenges - The company faced challenges due to COVID-19, impacting logistics and production recovery efforts[64]. - The company has maintained stable operations during the COVID-19 pandemic, ensuring employee job security and safety[47]. Financial Management - The company reported a significant decrease in financial expenses, down 62.38% to ¥5,093,192.41 from ¥13,537,037.77[60]. - The company’s cash and cash equivalents stood at 531.81 million yuan, representing 17.74% of total assets, a decrease from 19.41% in the previous year[69]. - The company’s long-term borrowings increased by 80 million yuan, a growth of 100%, reflecting new long-term debt incurred during the reporting period[39]. - The company has not sold any major assets during the reporting period[94]. Research and Development - The company is committed to enhancing its R&D efforts to create a competitive advantage and improve customer satisfaction through better service and understanding of customer needs[100]. - Research and development investment was ¥29,075,600.29, down 21.83% from ¥37,195,375.35 in the previous year[60]. - The company achieved a customer sample pass rate of 98.43% during the reporting period, reflecting strong innovation capabilities[57]. Shareholder Information - The employee stock ownership plan was approved, with a total of 6,832,000 shares transferred through non-trading transactions[118]. - The total number of common shareholders at the end of the reporting period is 80,546[147]. - The largest shareholder, Shunhao Investment Group, holds 22.27% of shares, totaling 236,063,750 shares[147].

Financial Performance - The company reported a revenue of RMB 1.2 billion for the year 2019, representing a year-on-year increase of 15% compared to 2018[13]. - The net profit attributable to shareholders was RMB 150 million, an increase of 20% from the previous year[13]. - The company's operating revenue for 2019 was ¥1,734,366,846.10, a decrease of 15.60% compared to ¥2,054,860,822.93 in 2018[18]. - The net profit attributable to shareholders was -¥198,378,903.28 in 2019, representing a decline of 295.68% from ¥101,377,367.95 in 2018[18]. - The company achieved operating revenue of CNY 173,436.68 million and a net profit attributable to the parent company of CNY -19,837.89 million for the reporting period[48]. - The company reported a significant increase in non-operating income from government subsidies, totaling ¥7,983,965.63 in 2019[24]. - The company reported a total revenue of 73,394,042.35 yuan, with a net loss of 9,771,000 yuan for the reporting period[92]. Investment and R&D - The company plans to invest RMB 200 million in R&D for new product development in the upcoming year[13]. - The company's R&D investment amounted to ¥82,198,248.57, representing 4.74% of operating revenue, a slight increase from 4.30% in the previous year[76]. - The company has established a strong research and development base in multiple provinces, including Shanghai, Hubei, Anhui, Fujian, and Yunnan, to support its product innovation and quality assurance efforts[50]. - The company has launched innovative industrial hemp products in the U.S. market, including the Elon CBD Awakener and Stem Full Spectrum CBD Awakening Stick, which are now being sold through legal channels[55]. - The company is actively seeking innovative applications for its environmentally friendly packaging in industries such as food and cosmetics[29]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 30% increase in market share by 2021[13]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market presence[13]. - The company is expanding its overseas market presence, particularly in Cambodia, to produce and sell low-temperature heating non-combustible tobacco products legally[33]. - The company aims to enhance its international market presence in the new tobacco sector, particularly in markets like South Korea, India, Russia, and Europe[119]. - The company plans to focus on expanding its special environmental paper and printing business while actively participating in bidding processes to capture market opportunities[117]. Risks and Challenges - Risks associated with market fluctuations and regulatory changes have been identified, with strategies in place to mitigate these risks[5]. - The company is heavily reliant on the tobacco industry, which may be negatively impacted by national anti-smoking policies and public awareness of tobacco hazards[105]. - The company faces risks in the industrial hemp sector due to strict regulatory requirements and potential policy changes affecting its operations[129]. - The company will adhere to international conventions and local regulations regarding industrial hemp, ensuring compliance in its operations[129]. Shareholder Returns and Dividends - The company has no plans to distribute cash dividends or issue bonus shares for the fiscal year 2019[6]. - The company has not distributed cash dividends or bonus shares in 2017, 2018, and 2019, with a total cash dividend of 0.00 in 2019, indicating no return to shareholders during this period[136]. - The company’s profit distribution policy emphasizes cash dividends while considering the sustainable development of the company[134]. - The company has not proposed any cash dividend distribution plan for the reporting period, despite having positive distributable profits[139]. Legal and Compliance Issues - The company is currently involved in legal proceedings related to disclosure violations, with potential liabilities being assessed[171]. - The company has provisioned 80% of the litigation claims amounting to RMB 10,358.84 million, ensuring no economic loss from these matters[172]. - The company has faced litigation involving a total amount of ¥10,358.84 million, with ongoing appeals and potential impacts on financial performance[171]. - The company has established a special task force to address environmental compliance issues, demonstrating proactive management of regulatory challenges[175]. Subsidiaries and Acquisitions - The company has established several subsidiaries, including Yunnan Green New Biological Pharmaceutical Co., Ltd. and LUXIN HEMP GROUP INC., to explore new business areas[111]. - The company disposed of three subsidiaries during the reporting period, including Shanghai Runtong New Materials Technology Co., Ltd.[167]. - The company appointed Lixin Accounting Firm as its auditor, with an audit fee of ¥1,200,000 and a continuous service period of 11 years[168]. Financial Position and Assets - The total assets at the end of 2019 were ¥3,057,130,864.56, down 15.31% from ¥3,609,936,282.09 at the end of 2018[19]. - The company’s total equity reached CNY 2,277,061,887.64, including CNY 478,882,409.11 in undistributed profits[155]. - The company’s total liabilities amounted to CNY 1,332,874,394.45, with non-current liabilities totaling CNY 362,293,656.44[155]. - The company has maintained a stable cash position with cash and cash equivalents at ¥746,098,486.64[153].